Sulphachlorpyridazine |
![]() Last updated: 06/09/2025 |
![]() |
(Also known as: sulfachlorpyridazine; BA-10370) |
|
![]() |
|
An antibacterial / antibiotic veterinary medicine used to control a range of infections | |
---|---|---|
|
Used to treat urinary tract and other bacterial infections | |
|
Pigs; Poultry; Calves |
Approval status |
|
Not approved | |
---|---|---|
|
Not approved |
Chemical structure |
|
None | |
---|---|---|
|
C₁₀H₉ClN₄O₂S | |
|
C1=CC(=CC=C1N)S(=O)(=O)NC2=NN=C(C=C2)Cl | |
|
No data | |
|
XOXHILFPRYWFOD-UHFFFAOYSA-N | |
|
InChI=1S/C10H9ClN4O2S/c11-9-5-6-10(14-13-9)15-18(16,17)8-3-1-7(12)2-4-8/h1-6H,12H2,(H,14,15) | |
|
Yes |
|
![]() |
Common Name | Relationship | Link |
---|---|---|
sulphachlorpyridazine | - | ![]() |
General status |
|
Antibiotic, Microbiocide, Antimicrobial, Antibacterial | |
---|---|---|
|
Sulfonamide | |
|
- | |
|
- | |
|
Synthetic | |
|
Inhibits folic acid synthesis in prokaryotes | |
|
[Dihydropteroate synthase, Inhibitor] | |
|
80-32-0 | |
|
201-269-9 | |
|
- | |
|
- | |
|
- | |
|
Antiinfectants for systemic use: Antibacterials for systemic use | |
|
QJ01EW12 | |
|
No | |
|
Allowed substance (Table 1: All food producing species) | |
|
284.72 | |
|
- | |
|
4-amino-N-(6-chloropyridazin-3-yl)benzenesulfonamide | |
|
4-amino-N-(6-chloro-3-pyridazinyl)benzenesulfonamide | |
|
- | |
|
- | |
|
- | |
|
- | |
|
Commercial |
|
|
|
|
|
||||||
---|---|---|---|---|---|---|---|---|---|---|
|
Current | |||||||||
|
- | |||||||||
|
Cosumix Plus powder for oral solution | Novartis Animal Health Ltd | Not licensed | Not licensed | ||||||
|
- | |||||||||
|
The production of sulphachlorpyridazine involves a multi-step chemical synthesis starting with sulfanilamide, which serves as the sulfonamide backbone. This compound undergoes a nucleophilic substitution reaction with 6-chloro-3-pyridazine sulfonyl chloride, forming the key bond between the sulfanilamide and the pyridazine ring. The reaction typically takes place in an organic solvent under controlled temperature and pH conditions to ensure high yield and purity. After the coupling step, the crude product is subjected to filtration, washing, and recrystallisation to remove impurities and isolate the active pharmaceutical ingredient. | |||||||||
|
Published GHG data is not available for most pharmaceuticals. However, according to industry, global averages suggest producing 1 kg of a typical active pharmaceutical ingredient can range from 10 to 100 kg CO₂e for small molecule drugs and potentially up to 1000 kg CO₂e for complex biologicals such as vaccines, depending on the drug type, its formulation, complexity of synthesis, solvent recovery, and energy sources used. |
|
![]() |
|
|
|
|
||||||||
---|---|---|---|---|---|---|---|---|---|---|---|
|
7000 | V3 V = ChemID Online Databases; Chemspider; PubChem. (ChemID ) 3 = Unverified data of known source |
High | ||||||||
|
- | - | - | ||||||||
|
187 | V3 V = ChemID Online Databases; Chemspider; PubChem. (ChemID ) 3 = Unverified data of known source |
- | ||||||||
|
- | - | - | ||||||||
|
- | - | - | ||||||||
|
- | - | - | ||||||||
|
|
2.04 X 1000 | Calculated | - | |||||||
|
0.31 | R4 R = Peer reviewed scientific publications 4 = Verified data |
Low | ||||||||
|
|
- | - | - | |||||||
|
- | - | - | ||||||||
|
- | - | - | ||||||||
|
1.40 | R4 R = Peer reviewed scientific publications 4 = Verified data |
- | ||||||||
- | |||||||||||
|
- | - | - | ||||||||
|
- | - | - | ||||||||
|
|
- | - | - | |||||||
|
- | - | - | ||||||||
|
- | - | - | ||||||||
|
- | - | - | ||||||||
|
- | - | - | ||||||||
|
- |
Degradation |
|
|
|
|
||||||||
---|---|---|---|---|---|---|---|---|---|---|---|
|
|
17 | R4 R = Peer reviewed scientific publications 4 = Verified data |
Non-persistent | |||||||
|
- | - | - | ||||||||
|
- | - | - | ||||||||
|
- | - | - | ||||||||
|
- | - | - | ||||||||
|
General literature states DT₅₀ range 3.5-21 days | ||||||||||
|
<8.0 | R4 R = Peer reviewed scientific publications Slightly persistent; Other data 127 days for slurry4 = Verified data |
- | ||||||||
|
|
- | - | - | |||||||
|
- | ||||||||||
|
|
- | - | - | |||||||
|
- | ||||||||||
|
- | - | - | ||||||||
|
- | - | - | ||||||||
|
- | - | - | ||||||||
|
As this parameter is not normally measured directly, a surrogate measure is used: ‘Photochemical oxidative DT₅₀’. Where data is available, this can be found in the Fate Indices section below. | ||||||||||
|
- |
Soil adsorption and mobility |
|
|
|
|
||||||||
---|---|---|---|---|---|---|---|---|---|---|---|
|
|
- | R4 R = Peer reviewed scientific publications 4 = Verified data |
Mobile | |||||||
|
43 | ||||||||||
|
General literature states Koc range 3.3-82 mL g⁻¹ | ||||||||||
|
|
- | - | - | |||||||
|
- | ||||||||||
|
- | ||||||||||
|
- | ||||||||||
|
- |
Fate indices |
|
|
|
|
||||||||||||||||||||||||||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
|
2.91 | Calculated | High leachability | ||||||||||||||||||||||||||
|
|
- | - | - | |||||||||||||||||||||||||
|
- | - |
Known metabolites |
None
|
![]() |
Terrestrial ecotoxicology |
|
|
|
|
||||||||
---|---|---|---|---|---|---|---|---|---|---|---|
|
- | - | - | ||||||||
|
|
- | - | - | |||||||
|
- | - | |||||||||
|
- | - | - | ||||||||
|
- | - | - | ||||||||
|
- | - | - | ||||||||
|
- | - | - | ||||||||
|
- | - | - | ||||||||
|
- | - | - | ||||||||
|
- | - | - | ||||||||
|
|
- | - | - | |||||||
|
- | - | - | ||||||||
|
|
- | - | - | |||||||
|
- | - | - | ||||||||
|
|
- | - | - | |||||||
|
- | - | - | ||||||||
|
- | - | - | ||||||||
|
- | - | - | ||||||||
|
- | ||||||||||
|
|
- | - | - | |||||||
- | |||||||||||
|
- | - | - | ||||||||
- | |||||||||||
|
|
- | - | - | |||||||
|
- | - | - | ||||||||
|
|
- | - | - | |||||||
|
- | ||||||||||
|
|
- | - | - | |||||||
|
- | ||||||||||
|
- | - | - | ||||||||
|
- | - | - | ||||||||
|
- | - | - | ||||||||
|
- | - | - | ||||||||
|
- | - | - |
Aquatic ecotoxicology |
|
|
|
|
||||||||
---|---|---|---|---|---|---|---|---|---|---|---|
|
535.7 | R4 R = Peer reviewed scientific publications Oryzias latipes4 = Verified data |
Low | ||||||||
|
- | - | - | ||||||||
|
- | - | - | ||||||||
|
0.375 | R4 R = Peer reviewed scientific publications Daphnia magna4 = Verified data |
Moderate | ||||||||
|
- | - | - | ||||||||
|
- | - | - | ||||||||
|
- | - | - | ||||||||
|
- | - | - | ||||||||
|
- | - | - | ||||||||
|
- | - | - | ||||||||
|
- | - | - | ||||||||
|
- | - | - | ||||||||
|
- | - | - | ||||||||
|
- | - | - | ||||||||
|
|
- | - | - |
|
- | - | - | |||
|
- | - | - |
|
![]() |
General |
|
|
|
|
||||||||
---|---|---|---|---|---|---|---|---|---|---|---|
|
High (class III) | - | - | ||||||||
|
- | - | - | ||||||||
|
- | - | - | ||||||||
|
- | - | - | ||||||||
|
- | - | - | ||||||||
|
- | - | - | ||||||||
|
- | - | - | ||||||||
|
- | - | - | ||||||||
|
- | - | - | ||||||||
|
- | - | - | ||||||||
|
- | - | - | ||||||||
|
|
- | |||||||||
|
- | ||||||||||
|
Elimination may occur in the urine, bile, feces, sweat, tears, or milk | Q3 Q = Miscellaneous data from online sources 3 = Unverified data of known source |
- |
Health issues |
|
|
||||||||||||||||||||||||||||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
|
Ingestion of sulfonamide can cause nausea, vomiting & diarrhoea Possible kidney, gastrointestinal & liver toxicant |
Handling issues |
|
|
|||
---|---|---|---|---|
|
Light sensitive | |||
|
- | |||
|
Not listed (Not listed) | |||
|
- | |||
|
- | |||
|
- |
|
![]() |
|
|
||
---|---|---|---|
|
sulphachlorpyridazine | ||
|
sulfachlorpyridazine | ||
|
Sulfachlorpyridazine | ||
|
- | ||
|
- | ||
|
sulfacloropiridazina | ||
|
- | ||
|
- | ||
|
- | ||
|
- | ||
|
- | ||
|
- |
Record last updated: | 06/09/2025 |
Contact: | aeru@herts.ac.uk |
Please cite as: | Lewis, K.A., Tzilivakis, J., Warner, D. and Green, A. (2016) An international database for pesticide risk assessments and management. Human and Ecological Risk Assessment: An International Journal, 22(4), 1050-1064. DOI: 10.1080/10807039.2015.1133242 |